目的克隆人血管紧张素转换酶2基因（ACE2），并构建其真核表达载体。
Objective To clone the human angiotensin-converting enzyme 2 (ACE2)and construct its eukaryotic expression plasmid.
人血管紧张素转换酶2（ACE2）是目前已知的惟一的人血管紧张素转换酶（ACE）的同源物，是一种新型的金属羧肽酶，很多特性与ACE截然不同。
Human angiotensin-converting enzyme 2(ACE2), an only known homologue of human ACE, is a novel metallocarboxypeptidase with characteristics distinct from those of ACE.
而那些能降低房颤发病的因素有胸痛(OR 0.35)，非白种人(OR 0.61)，糖尿病(OR 0.67)和血管紧张素转换酶抑制剂的应用(OR 0.63)。
Factors that significantly reduced AF onset included chest pain (or 0.35), non-Caucasian race (or 0.61), diabetes (or 0.67) and ace inhibitor use (or 0.63).
应用推荐